Compile Data Set for Download or QSAR
Found 178 with Last Name = 'burk' and Initial = 'rm'
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202319(US9540357, example 14 | US9540357, example 15)copy SMILEScopy InChI
Affinity DataKi:  6nM ΔG°:  -46.9kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202325(US9540357, example 16 | US9540357, example 17)copy SMILEScopy InChI
Affinity DataKi:  11nM ΔG°:  -45.4kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85339(17-PHENYL TRINOR PGF2ALPHA-IPR | CAS_130209-76-6 |...)copy SMILEScopy InChI
Affinity DataKi:  18nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202318(US9540357, example 13)copy SMILEScopy InChI
Affinity DataKi:  23nM ΔG°:  -43.6kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202307(US9540357, example 10 | US9540357, example 9)copy SMILEScopy InChI
Affinity DataKi:  25nM ΔG°:  -43.4kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85720(AGN 194394)copy SMILEScopy InChI
Affinity DataKi:  34nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM50020300((S-isomer)7-[3,5-Dihydroxy-2-(3-hydroxy-oct-1-enyl...)copy SMILEScopy InChI
Affinity DataKi:  45nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM50020300((S-isomer)7-[3,5-Dihydroxy-2-(3-hydroxy-oct-1-enyl...)copy SMILEScopy InChI
Affinity DataKi:  48nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202310(US9540357, example 11 | US9540357, example 12)copy SMILEScopy InChI
Affinity DataKi:  53nM ΔG°:  -41.5kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202331(US9540357, example 20 | US9540357, example 21)copy SMILEScopy InChI
Affinity DataKi:  60nM ΔG°:  -41.2kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85718(AGN 191366)copy SMILEScopy InChI
Affinity DataKi:  71nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202345(US9540357, example 24 | US9540357, example 25)copy SMILEScopy InChI
Affinity DataKi:  130nM ΔG°:  -39.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202340(US9540357, example 22 | US9540357, example 23)copy SMILEScopy InChI
Affinity DataKi:  140nM ΔG°:  -39.1kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202305(US9540357, example 7 | US9540357, example 8)copy SMILEScopy InChI
Affinity DataKi:  159nM ΔG°:  -38.8kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85339(17-PHENYL TRINOR PGF2ALPHA-IPR | CAS_130209-76-6 |...)copy SMILEScopy InChI
Affinity DataKi:  168nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202452(US9540357, example 30 | US9540357, example 31)copy SMILEScopy InChI
Affinity DataKi:  211nM ΔG°:  -38.1kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202319(US9540357, example 14 | US9540357, example 15)copy SMILEScopy InChI
Affinity DataKi:  216nM ΔG°:  -38.0kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85716(AGN 191995)copy SMILEScopy InChI
Affinity DataKi:  228nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85715(AGN 191365)copy SMILEScopy InChI
Affinity DataKi:  307nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202394(US9540357, example 28 | US9540357, example 29)copy SMILEScopy InChI
Affinity DataKi:  319nM ΔG°:  -37.1kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202325(US9540357, example 16 | US9540357, example 17)copy SMILEScopy InChI
Affinity DataKi:  332nM ΔG°:  -37.0kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202472(US9540357, example 34 | US9540357, example 35)copy SMILEScopy InChI
Affinity DataKi:  352nM ΔG°:  -36.8kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202460(US9540357, example 32 | US9540357, example 33)copy SMILEScopy InChI
Affinity DataKi:  536nM ΔG°:  -35.8kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202452(US9540357, example 30 | US9540357, example 31)copy SMILEScopy InChI
Affinity DataKi:  582nM ΔG°:  -35.6kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202329(US9540357, example 18 | US9540357, example 19)copy SMILEScopy InChI
Affinity DataKi:  658nM ΔG°:  -35.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202354(US9540357, example 26 | US9540357, example 27)copy SMILEScopy InChI
Affinity DataKi:  757nM ΔG°:  -34.9kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202331(US9540357, example 20 | US9540357, example 21)copy SMILEScopy InChI
Affinity DataKi:  955nM ΔG°:  -34.4kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202485(US9540357, example 36 | US9540357, example 37)copy SMILEScopy InChI
Affinity DataKi:  1.08E+3nM ΔG°:  -34.1kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202305(US9540357, example 7 | US9540357, example 8)copy SMILEScopy InChI
Affinity DataKi:  1.15E+3nM ΔG°:  -33.9kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202290(US9540357, example 1 | US9540357, example 2)copy SMILEScopy InChI
Affinity DataKi:  1.21E+3nM ΔG°:  -33.8kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202345(US9540357, example 24 | US9540357, example 25)copy SMILEScopy InChI
Affinity DataKi:  1.31E+3nM ΔG°:  -33.6kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202310(US9540357, example 11 | US9540357, example 12)copy SMILEScopy InChI
Affinity DataKi: >1.34E+3nM ΔG°: >-33.5kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202290(US9540357, example 1 | US9540357, example 2)copy SMILEScopy InChI
Affinity DataKi:  2.04E+3nM ΔG°:  -32.5kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202340(US9540357, example 22 | US9540357, example 23)copy SMILEScopy InChI
Affinity DataKi:  2.34E+3nM ΔG°:  -32.1kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85719(PGF2 Alpha, 1-isopropyl ester)copy SMILEScopy InChI
Affinity DataKi:  3.20E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202307(US9540357, example 10 | US9540357, example 9)copy SMILEScopy InChI
Affinity DataKi:  3.32E+3nM ΔG°:  -31.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202318(US9540357, example 13)copy SMILEScopy InChI
Affinity DataKi:  4.32E+3nM ΔG°:  -30.6kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202472(US9540357, example 34 | US9540357, example 35)copy SMILEScopy InChI
Affinity DataKi:  4.34E+3nM ΔG°:  -30.6kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202485(US9540357, example 36 | US9540357, example 37)copy SMILEScopy InChI
Affinity DataKi:  4.48E+3nM ΔG°:  -30.5kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202460(US9540357, example 32 | US9540357, example 33)copy SMILEScopy InChI
Affinity DataKi:  4.83E+3nM ΔG°:  -30.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202293(US9540357, example 3 | US9540357, example 4)copy SMILEScopy InChI
Affinity DataKi:  4.97E+3nM ΔG°:  -30.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85719(PGF2 Alpha, 1-isopropyl ester)copy SMILEScopy InChI
Affinity DataKi:  5.00E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202394(US9540357, example 28 | US9540357, example 29)copy SMILEScopy InChI
Affinity DataKi:  5.16E+3nM ΔG°:  -30.2kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202296(US9540357, example 5 | US9540357, example 6)copy SMILEScopy InChI
Affinity DataKi:  6.71E+3nM ΔG°:  -29.5kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetSolute carrier organic anion transporter family member 2A1(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85714(AGN 190911)copy SMILEScopy InChI
Affinity DataKi:  7.30E+3nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202290(US9540357, example 1 | US9540357, example 2)copy SMILEScopy InChI
Affinity DataKi:  7.49E+3nM ΔG°:  -29.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP2 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202485(US9540357, example 36 | US9540357, example 37)copy SMILEScopy InChI
Affinity DataKi:  7.49E+3nM ΔG°:  -29.3kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin F2-alpha receptor(Homo sapiens (Human))
Albert Einstein College of Medicine

Curated by PDSP Ki Database
LigandPNGBDBM85718(AGN 191366)copy SMILEScopy InChI
Affinity DataKi:  8.13E+3nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2WD3Z4BPubMed
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202296(US9540357, example 5 | US9540357, example 6)copy SMILEScopy InChI
Affinity DataKi:  8.56E+3nM ΔG°:  -28.9kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
TargetProstaglandin E2 receptor EP4 subtype(Homo sapiens (Human))
Allergan, Inc.

US Patent
LigandPNGBDBM202354(US9540357, example 26 | US9540357, example 27)copy SMILEScopy InChI
Affinity DataKi:  8.85E+3nM ΔG°:  -28.8kJ/molepH: 7.4 T: 2°CAssay Description:A 384-well drug plate was prepared to contain 6 test compounds, PGE2 and cAMP in 16 serial dilutions in triplicate, using a Biomek station. HEK-EBNA ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q24M92QQUS Patent
Displayed 1 to 50 (of 178 total ) | Next | Last >>
Jump to: